Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Kuwait

Hikma To Acquire Remaining Shares In JPI

April 2006 | FDI Alert

Jordanian drugmaker Hikma has announced that it is to acquire the 52.5% of its Saudi Arabian subsidiary Al Jazeera Pharmaceuticals Industries (JPI) that it does not already own, for SAR78.75 (US$20.93mn). The transaction is scheduled for completion by the end of June 2006. Hikma has had a 47.5% stake in JPI since it was founded in 1994.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Hikma On Upward Track

Companies / Kuwait Hikma's 2007 performance is being hailed as a success by industry observers. The company's full-year results for 2007 revealed that sales were up by a massive 41.6% on 2006, to US$448mn, while pre-tax...
March 2008
Hikma - In Favour, But In Debt

Companies / Kuwait In October 2007 BMI reported on Jordanian drugmaker Hikma Pharmaceuticals' bid for local rival Arab Pharmaceutical Manufacturing Company (APM). December 2007 saw the bid accepted; however, the cost to...
January 2008
Hikma Bids For Local Rival

Companies / Kuwait In a move that would ensure its dominance of the local pharmaceutical market, Jordan's largest drugmaker Hikma has launched a JOD116mn (US$164mn) bid to acquire rival Arab Pharmaceutical Manufacturing...
October 2007
Dar Al Dawa Records Solid Results

Companies / Kuwait Jordanian drugmaker Dar Al Dawa (DADI) recorded sales of JOD32.84mn (US$46.26mn) in 2005, with net income reaching JOD7.71mn (US$10.87mn), an increase of 7.27% compared to the same period last year....
April 2006
Hikma Announces Strong Sales

Companies / Kuwait Jordanian drugmaker Hikma has announced sales of US$262mn in 2005, an increase of 23.5% compared to the same period last year. Meanwhile profits reached US$135.8mn, up 25.2%. This strong performance...
April 2006
Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS